课题基金 / 基金详情

Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare

Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare
利用先进的临床表型来增强问题清单并支持基于价值的医疗保健
批准号:
9762237
负责人:
Daniel Jay Riskin
金额:
$74.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2020-08-31

项目摘要

项目成果

Daniel Jay Riskin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary With newly available electronic health data and a massive increase in processing power, data-driven personalized medicine is just now becoming possible.1 However, advances to improve health care are inherently limited by data quality. One of the most used sources of data, the patient problem list, is also the greatest source of data inaccuracy. According to recent studies, the patient problem list is often less than 50% accurate in documenting the most critical conditions.2 3 4 5 These errors exacerbate inefficiencies throughout the American health care system from care delivery to quality improvement. Primary care physicians rely on problem lists to develop transitional treatment plans for the 68 million Americans who change providers every year. Errors related to care transitions harm more than 1.5 million people each year in the United States, costing the nation an estimated $3.5 billion annually.6 Population health efforts, a cornerstone of value-based healthcare, rely on problem lists to determine risk levels and deployment of resources. These efforts cannot succeed if the source data produce faulty results. This application seeks to enable better individual patient care, enhanced population health management, and effective downstream analytics by building an automated problem list builder, which provides an accurate and granular account of the patient’s medical conditions. If the program is successful, one of the greatest technical risks in value-based healthcare will be addressed. Phase I exceeded success criteria in proving feasibility of core modules in natural language processing (NLP) and artificial intelligence. Based on Phase I success, implementation pathways are demonstrated through pilots with one of the largest US healthcare systems and one of the largest global biotechnology firms. The team is comprised of commercial and academic leaders in the field of NLP-based products applied to value-based healthcare.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s12911-023-02190-8
发表时间: 2023-07-14
期刊: BMC medical informatics and decision making
影响因子: 3.5
作者: []
通讯作者:
Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST)
  • 批准号:
    10450726
  • 项目类别:
  • 资助金额:
    $189.54万
  • 财政年份:
    2020
  • 负责人:
    Daniel Jay Riskin
  • 依托单位:
Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST)
  • 批准号:
    10256676
  • 项目类别:
  • 资助金额:
    $189.54万
  • 财政年份:
    2020
  • 负责人:
    Daniel Jay Riskin
  • 依托单位:
Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST)
  • 批准号:
    10180783
  • 项目类别:
  • 资助金额:
    $189.54万
  • 财政年份:
    2020
  • 负责人:
    Daniel Jay Riskin
  • 依托单位:
Enabling value-based healthcare through automating risk assessment for episode-based care
  • 批准号:
    9464424
  • 项目类别:
  • 资助金额:
    $22.26万
  • 财政年份:
    2017
  • 负责人:
    Daniel Jay Riskin
  • 依托单位:
海外基金